Opko Health, Inc.
OPK
$1.13
$0.021.35%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 124.20M | 148.45M | 151.67M | 156.81M | 149.95M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 124.20M | 148.45M | 151.67M | 156.81M | 149.95M |
| Cost of Revenue | 81.18M | 117.20M | 131.85M | 137.75M | 109.95M |
| Gross Profit | 43.02M | 31.25M | 19.82M | 19.06M | 40.00M |
| SG&A Expenses | 48.61M | 55.22M | 53.80M | 59.60M | 59.09M |
| Depreciation & Amortization | 18.97M | 19.06M | 19.53M | 19.44M | 19.86M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 175.21M | 191.47M | 205.19M | 216.79M | 217.12M |
| Operating Income | -51.02M | -43.02M | -53.52M | -59.98M | -67.17M |
| Income Before Tax | -60.96M | -46.92M | 41.43M | -162.52M | -73.38M |
| Income Tax Expenses | -6.11M | -15.66M | 19.80M | -14.08M | -5.77M |
| Earnings from Continuing Operations | -54.85M | -31.26M | 21.63M | -148.44M | -67.61M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -54.85M | -31.26M | 21.63M | -148.44M | -67.61M |
| EBIT | -51.02M | -43.02M | -53.52M | -59.98M | -67.17M |
| EBITDA | -28.82M | -20.64M | -30.78M | -36.95M | -43.68M |
| EPS Basic | -0.07 | -0.04 | 0.03 | -0.19 | -0.10 |
| Normalized Basic EPS | -0.05 | -0.04 | -0.05 | -0.13 | -0.07 |
| EPS Diluted | -0.07 | -0.04 | 0.03 | -0.19 | -0.10 |
| Normalized Diluted EPS | -0.05 | -0.04 | -0.05 | -0.13 | -0.07 |
| Average Basic Shares Outstanding | 758.88M | 765.52M | 777.15M | 788.01M | 671.58M |
| Average Diluted Shares Outstanding | 758.88M | 765.52M | 779.92M | 788.01M | 671.58M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |